Anti-aging startup raises $116M from Jeff Bezos, Mayo Clinic
Unity Biotechnology, a startup developing anti-aging medicines, has raised $116 million in a Series B funding round led by Amazon Founder Jeff Bezos and Mayo Clinic, among others. The company also announced that the former CEO of KYTHERA Biopharmaceuticals, Keith Leonard, would assume the position of CEO, and the previous CEO and Co-Founder Nathaniel David will be Unity's President.